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Abstract  1 
Endophytic fungi associated with medicinal plants are a potential source of novel chemistry and 2 
biology. Metabolomic tools were successfully employed to compare the metabolite fingerprints of 3 
solid and liquid culture extracts of endophyte Curvularia sp. isolated from the leaves of Terminalia 4 
laxiflora. Natural product databases were used to dereplicate metabolites in order to determine 5 
known compounds and the presence of new natural products. Multivariate analysis highlighted the 6 
putative metabolites responsible for the bioactivity of the fungal extract and its fractions on NF-7 
kappaB and the myelogenous leukemia cell line K562. Metabolomic tools and dereplication studies 8 
using HRESIMS directed the fractionation and isolation of the bioactive components from the 9 
fungal extracts.  This resulted in the isolation of N-acetylphenylalanine (1) and two linear peptide 10 
congeners of 1: dipeptide N-acetylphenylalanyl-L-phenylalanine (2) and tripeptide N-11 
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Introduction 1 
In our search for new potential anticancer agents from endophytic fungi of Egyptian medicinal 2 
plants, Terminalia laxiflora (Combretaceae) was among the plants chosen for this study. In Egypt, 3 
T. laxiflora has been used to treat yaws, diarrhea, dysentery, and pulmonary troubles. Extracts and 4 
isolated compounds from plants of the genus Terminalia have been reported not only for their 5 
cytotoxicity [1-3], antioxidant and free radical scavenging effects [4-6] but as well as induction of 6 
cell cycle arrest and apoptosis [7-9]. Chebulagic acid from T. chebula was described to synergize 7 
the cytotoxicity of doxorubicin in human hepatocellular carcinoma [10].  T. catappa exhibited 8 
antimetastatic effects on hepatocellular carcinoma by modulating NF-kappaB and AP-1 activity 9 
[11]. Moreover, like the other members of the genus, T. laxiflora is rich with hydrolysable tannins 10 
and phenols, which were described as cancer cell growth inhibitors [12]. In addition, taxol-11 
producing fungal endophytes Pestalotiopsis terminaliae [13] and Chaetomella raphigera [14] have 12 
also been isolated from T. arjuna (arjun tree).  These earlier reports on the genus Terminalia 13 
prompted us to look into the endophytes of T. laxiflora from which we isolated three endophytic 14 
fungi, Aspergillus aculeatus, Aspergillus oryzae and Curvularia sp.  Endophytes are microbes that 15 
inhabit living, internal tissues of plants without causing any immediate, apparent negative effects 16 
[15].  Endophytes associated with plants are an infinite undisclosed reservoir of chemically diverse 17 
natural products. Advanced methods in cultivation and dereplication procedures have provided 18 
access to a rich source of novel drug leads, having the advantage of vast-effective production 19 
through large-scale cultivation of the microorganisms. In many cases, endophytic fungi might be 20 
involved in the biosynthesis of plant natural products, but they might also be themselves the 21 
producers of new pharmacologically active and structurally diverse secondary metabolites [16]. 22 
 4 
In the preliminary screening, fungal extracts from both A. aculeatus and oryzae were found to be 1 
active against the prostate cancer cell line (PC-3) [17] while some of the prepared Curvularia 2 
extracts inhibited the growth of chronic myelogenous leukemia cell (K562). Between 2009 and 3 
2013, leukemia was the fifth and the sixth most common cause of cancer deaths in men and women, 4 
respectively [18]. According to the International Agency for Research on Cancer (IARC), there 5 
were 351,965 cases of leukemia diagnosed worldwide in 2012. The number of deaths was 265,471 6 
that is more than 75% on the incidence numbers [19].  To date, in 2017, 24,500 people are likely to 7 
die from leukemia (14,300 males and 10,200 females) [18]. According to the American Cancer 8 
Society, it is estimated that there are 363,794 people living with or in remission from leukemia [20].  9 
In this study, we focused on the isolation of the bioactive metabolites of a Curvularia extract against 10 
the leukemia cell line K562.  Metabolomic tools were employed to compare the metabolite 11 
fingerprints of solid and liquid culture extracts of a Curvularia sp. endophyte isolated from the 12 
leaves of T. laxiflora. Curvularia sp. was earlier found to be associated with both terrestrial and/or 13 
marine natural sources. Previous studies of endophytic Curvularia associated with marine alga 14 
[21,22] and the medicinal plant Murraya koenigii [23] yielded diverse types of curvularin 15 
macrolides, which exhibited a range of bioactivities like anticancer and antimicrobial activities 16 
[21,22].  17 
Production of the fungal bioactive metabolites was targeted through a metabolomics approach [24-18 
26]. Putative metabolites responsible for the activity of the fungal extracts and fractions against 19 
leukemia cell lines were then pinpointed by multivariate analysis. In parallel, a natural product 20 
database was utilized to dereplicate metabolites in order to identify the known compounds and the 21 
presence of new natural products.   22 
 23 
 5 
Results and Dicussion 1 
By repeated inoculation on Malt-Agar (MA) plates, purified colonies of Curvularia sp. (strain code: 2 
TL-F2A) was isolated from the surface-sterilized leaves of Terminalia laxiflora collected from Al-3 
Zohria gardens, Giza, Egypt.  The fungal extract of a MA plate of Curvularia exhibited neither 4 
anticancer nor antimicrobial activities. However, metabolomic profiling of extracts from two other 5 
different media, which were liquid broth (LC) and rice (RC), exhibited a change in chemical 6 
profiles as shown by the heat map analysis of their mass spectral data (Fig. 1).  The m/z peaks are 7 
indicated by bands. The occurrence of more blue bands represented the diversity of the metabolites 8 
in terms of their occurrence and increase in intensity of respective metabolites prior to the 9 
normalized average yield. The red bands signified the absence or decrease in intensity of respective 10 
metabolites. On different culture media prepared in triplicates, optimal growth was observed in 30-11 
days agar plate, 15-days liquid broth, and 30-days rice cultures.  The 7- and 30-days rice cultures 12 
exhibited the highest chemical diversity. However, the displayed chemical diversity for the 7-days 13 
rice culture represents the unutilized media constituents originating from the malt agar inoculum. 14 
For the 15-days rice culture, low production of metabolites was observed. An increase in metabolite 15 
production was exhibited by the 30-days rice culture.  16 
HR-LCMS metabolite profiling data for the rice culture extracts processed via MZmine 2.10 17 
(modified version) [25] also detected more metabolites from both the 7- and 30-days than the 15-18 
days incubation period as shown by the scatter plots (Fig. 2). From the scatter plot between the 7- 19 
and 30-days culture (Fig. 2C), it was also observed that a different set of metabolites were being 20 
synthesized and degraded over the respective incubation periods as unique metabolites were 21 
indicated below and above the diagonal. As exhibited by both the heat-map and scatter plots, an 22 
incubation period of 15 days was an intermediate stage when nutrients are being depleted.  As a 23 
 6 
survival mechanism for the fungus to beat environmental stress that also includes nutrient depletion, 1 
secondary metabolites are produced during the lag phase, which occurred at a period of 30 days on 2 
the rice culture media. 3 
The change in chemical profile between culture media and duration of incubation raised a question 4 
whether these different fermentation conditions will demonstrate any change in the bioactivity. 5 
Investigation of the biological activity of the metabolite-rich 7- and 30-days rice culture extracts 6 
showed that only the 30-days culture extract of Curvularia sp. exhibited a good inhibition activity of 7 
70% against NF-kappaB at 30 Pg/mL. NF-kappaB is a protein complex that controls transcription of 8 
DNA and responsible for cytokine production as well as cell survival [27].  NF-kappaB activation 9 
contributes to proliferation and survival of a variety of cancer cells. NF-kappaB inhibition 10 
substantially suppresses tumor growth and angiogenesis. Compounds described to inhibit NF-11 
kappaB may exhibit anti-cancer activity [28] while NF-kappaB activation also plays a major role in 12 
the regulation of proinflammatory and prothrombotic responses [29] making NF-kappaB inhibition 13 
important against inflammation-associated cancer development. 14 
Multivariate analysis of the mass spectral data of the fungal and host plant extracts by Principal 15 
Component Analysis (PCA), an unsupervised classification method discriminated both the 7- and 16 
30-days culture extracts (Fig 3A) indicating the presence of exclusive metabolites produced during 17 
these growth phases. The unique metabolites found on the bioactive 30-days culture extract were 18 
identified on the PCA loading plot (Fig 3B), and then dereplicated using the Dictionary of Natural 19 
products (DNP) database as shown in Table 1. Some metabolites obtained from the fungal extracts 20 
were also detected in the crude leaf extracts of the host plant Terminalia laxiflora but at lower levels 21 
of concentration, which indicated that the isolated Curvularia IXQJXVLVD³WUXH´HQGRSK\WHRIT. 22 
laxiflora.  ³7UXH´HQGRSK\WLFIXQJLDUHLVRODWHGIURPLQWHUQDOKHDOWK\WLVVXHVZKRVHFRORQL]DWLRQLV23
 7 
not a result of visible symptoms of a disease [30]. Dereplicated metabolites with corresponding 1 
[M+H]+ ion peaks at m/z 208.0969, 355.1651 and 468.2495  eluted at a retention time of 6.54, 9.17 2 
and 11.55 minutes, respectively, were isolated from the scaled-up batch of the 30-days rice culture 3 
fungal extract by medium pressure liquid chromatography (MPLC). These metabolites were 4 
putatively identified as the drug afalanine or N-acetylphenylalanine (1), the lichen metabolite 5 
picroroccellin from Roccella fuciformis [31], and the fungal metabolite cyclopiamine B from 6 
Aspergillus caespitosus [32], respectively. However, only afalanine matched the identity of the 7 
isolated compound at m/z 208.0969. The purified compounds 1, 2, and 3 (Fig. 4) were 8 
chromatographically obtained from the active extracts and fractions that were tested against NF-9 
kappaB¶VDQWLDSRSWRWLF transcription factors in human Philadelphia chromosome-positive chronic 10 
myelogenous leukemia cells (K562). The NMR data of the isolated compounds 2 and 3 (Fig. 4) at 11 
m/z 355.1651 and 468.2495, respectively, did not match those of the dereplicated hits from the DNP 12 
database indicating that the afforded compounds were suspected novel natural products requiring 13 
further structure elucidation. 14 
Compound 1, which was purified from fraction CV96-103, exhibited 95% inhibition of NF-kappaB 15 
in K562 at a concentration of 100 Pg/mL (500 PM). Compound 3 was found to be inactive in the 16 
assays performed in this study.  As depicted by the S-plot (Fig. 5B), compound 3 was situated 17 
DOPRVWQHDUWKHµ]HUR¶scale RIWKHµ\¶D[LVWRZDUGVWKHTXDGUDQWRIWKHLQDFWLYHPHWDEROLWHV7KH18 
isolation of compound 3 was due to its co-occurrence with compound 2 in the same fractions. 19 
Compounds 2 and 3 (m/z 354.158 and 467.242, respectively) were both isolated from fraction CV4-20 
32 that gave a weaker growth inhibition of the K562 cell line by 70% when compared to fraction 21 
CV96-103, which contained a higher concentration of compound 1 (m/z 207.090) as shown by its 22 
peak area (Fig. 5C). Compounds 2 and 3 were also found in the inactive fractions but at very low 23 
 8 
concentrations as exhibited by their respective peak areas. The low concentration of 2 in the inactive 1 
fractions was below the potency level of the compound.     2 
The mass spectral data of the MPLC fractions and extracts were subjected to OPLS-DA by grouping 3 
them according to their bioactivities on NF-kappaB and K562. The bioactive fractions CV4-32, 4 
CV60-86, and CV96-103 were grouped together against the inactive fractions. Assayed at a 5 
concentration of 30 Pg/mL, fraction CV4-32 inhibited the growth of K562 cell line by 70%, while 6 
CV60-86 and CV96-103 both exhibited 95% inhibition.  The score plot (Fig. 5A) showed that the 7 
two active fractions CV4-32 and CV96-103 were clustered together while CV60-86 was an outlier 8 
and considered to have a more diverse chemistry. The S-loading plot (Fig. 5B) classified the 9 
putative distinct metabolites belonging to the active fractions, which included [M+H]+ ion peaks at 10 
m/z 208.0969 and 355.1651, representing compounds 1 and 2, respectively, also found on the 30-11 
day culture extract as shown in the PCA loading plot on Fig. 3B.  Furthermore, ion peaks at m/z 12 
172.0990 [M-H]- and 345.2050 [2M-H]- eluting at 5.41 min were also determined together with 13 
compounds 1 and 2DVDPRQJWKHQDWXUDOSURGXFWVSUHGLFWHGWREHUHVSRQVLEOHIRUWKHH[WUDFW¶V14 
bioactivities against NF-kappaB and K562.  The ion peak at m/z 172.0990 was dereplicated as N-15 
acetyl-leucine, however, it was not possible to isolate and purify the compound present from CV60-16 
86 due to a low fraction yield of 6.9 mg.  Compound 1 was identified in fractions CV60-86 and 17 
CV96-103, while compound 2 was identified in both fractions CV4-32 and CV60-86 (Fig. 5C).  18 
Compound 1 was isolated as a yellowish brown amorphous powder (8 mg), which exhibited a 19 
molecular formula of C11H13O3N established on the basis of ESI-HRMS at m/z 208.0969 20 
[M+H]+ (calcd. 208.0968), 890H2+Ȝmax ORJİ 228(5.03), 308 (5.09) nm. The 1H-NMR 21 
spectrum (DMSO-d6, 400 MHz) (Supporting Information Fig. 1S) showed six proton signals at 22 
įH 8.15 (d, 1H, J = 7.8 Hz), 7.24 (m, 5H), 4.37 (m, 1H), 3.04 (dd, 1H, J = 13.6, 3.9 Hz), 2.82 23 
 9 
(dd, 1H, J = 13.6, 9.5 Hz) and 1.77 (s, 3H). The structure of the amino acid spin system was 1 
detected via a 1H-1H TOCSY spectrum (Supporting Information Fig. 2S) which showed the 2 
correlation between the NH JURXSDWįH 8.15 and CH2A įH 3.04), CH2B įH DQGĮ-CHNH 3 
DWįH 4.37. Comparison of 1H- and 13C-NMR data of compound 1 (Table 2) with data from 4 
literature [33-35] along with the 2D spectra of the isolated compound, 1 was identified as the 5 
drug N-acetylphenylalanine (Fig. 4) also known as afalanine [36]. Afalanine is used as an 6 
antidepressant drug and in combination with antibiotics to prevent kidney damage [37].  7 
The configuration of the isolated N-acetyl-phenylalanine (1 ZDV HVWDEOLVKHG E\ 0DUIH\¶V8 
derivatisation implying an L configuration (Fig 3S). The NMR data and retention time of the 9 
compound 1 were identical to the commercially available D and L standards while the optical rotation 10 
of 1, [D]D25 = +12o (c 0.05 in MeOH), followed a similar signage as the L standard with a value of  11 
[D]D25 = +40o (c 0.05 in MeOH). The difference in magnitude of the optical rotation between the 12 
isolated compound and the standard could be due to the lower racemic purity of compound 1. 13 
Compound 2, obtained as a yellow powder (15 mg), which exhibited a molecular formula 14 
C20H22N2O4 established by ESI-HRMS at m/z 355.1645 [M+H]
+ (calcd 355.1652), 890H2+Ȝmax 15 
ORJİ 223 (5.53), 257 (5.27) nm. The tandem MS/MS spectrum (Fig. 6A, Supporting Information 16 
Fig. 4S) showed fragment ions at m/z 190.0867 and 166.0868 for N-acetyl-L-phenylalanine 17 
[C11H12O2N íOH] and phenylalanine [C9H10NO2] moieties, respectively. The 1H-NMR spectrum 18 
(DMSO-d6, 400 MHz) (Table 2, Supporting Information )LJ6VKRZHGSURWRQUHVRQDQFHVDWįH 19 
8.39 (d, J = 8.1 Hz, 1H), 8.35 (d, J = 8.5 Hz, 1H), 7.05-7.27 (m, 10H), 5.18 (m, 1H), 5.12 (m, 1H), 20 
2.43-2.70 (m, 4H) and 1.80 (s, 3H). The 13C-NMR spectrum (DMSO-d6, 100 MHz) (Table 2 and 21 
Supporting Information Fig. 6S) showed 20 carbon signals including five quaternary resonances, 22 
 10 
ten aromatic methines, two methylenes, and one methyl carbon. The TOCSY spectrum (Supporting 1 
Information Fig. 7S) showed two spin systems, a correlation between NH DWįH DQGĮ-CHNH-2 
2''' įH 5.12) and CH2-3''' įH 2.43-2.70) of a phenylalanine moiety, while the NH DWįH 8.35 3 
FRUUHODWHGZLWKĮ-CHNH-įH 5.18) and CH2-įH 2.43-2.70) of the N-acetyl-phenylalanine unit. 4 
The structure of the N-acetyl-phenylalanine was confirmed from the HMBC spectrum (Fig. 8S and 5 
Fig. $WKURXJKWKHFRUUHODWLRQVRIĮ-CHNH-įH 5.18) with C-įC 43.0), C-2'' įC 168.8), C-1' 6 
įC 143.3) and C-2'/6' įC 127.2). In addition, NH DWįH 8.35 showed a cross peak with C-2'' 7 
carbonyl and C-įC 50.5), the D carbon for N-acetyl-phenylalanine. The structure of a 8 
SKHQ\ODODQLQHPRLHW\ZDVFRQILUPHGWKURXJKWKHFRUUHODWLRQVRIDQĮ-CHNH-2''' at įH 5.12 with C-9 
1''' įC 172.3), C-3''' įC 41.3), C-įC 168.9), C-1'''' įC 142.8), C-2''''/6'''' įC 126.8); while the 10 
NH DWįH 8.39 correlated with C-1 and C-2''' at įC 7KHFRUUHODWLRQRIĮ-CHNH and NH of 11 
phenylalanine moiety with the carbonyl C-DWįC 168.9 of N-acetylphenylalanine confirmed the 12 
attachment of the two moieties through the amide linkage. Furthermore, the configuration of  13 
SKHQ\ODODQLQHZKHWKHULWLV'RU/DPLQRDFLGZDVDVVLJQHGWKURXJKGHULYDWL]DWLRQZLWK0DUIH\¶V14 
reagent FDAA (1% N-(1-flouro-2,4-dinitrophenyl)-5-L-alanine amide) [38] and HPLC-MS data of 15 
the derived products of analysis (Supporting Information Fig. 9S). The hydrolysis product of 16 
compound 2 UHDFWHGZLWK0DUIH\¶VUHDJHQWWRDIIRUG&18H20O7N5 at m/z 418.1355 [M+H]+ eluting at 17 
13.70 min which corresponded with the standard L-phenylalanine as the hydrolysis product. On the 18 
other hand, the D-phenylalanine standard eluted at 14.87 min. Compound 2 (Fig. 4) was identified 19 
as N-acetyl-L-phenylalanyl-L-phenylalanine [39], a dipeptide isolated for the first time from a 20 
natural source. N-acetyl amino acids are very useful in the pharmaceutical and food industries as 21 
they play an important role in methylation, sulfuration, detoxication and antioxidation [39]. The 22 
related natural product N-acetyl-L-phenylalanyl-L-phenylalaninol has been previously isolated from 23 
 11 
culture filtrates of the fungus Emericellopsis salmosynnemata [40], a producer of the peptide 1 
antibiotic zervamicin [41,42]. The hydroxylated methylene unit found in N-acetyl-L-phenylalanyl-2 
L-phenylalaninol was instead substituted by a carboxylic acid moiety in compound 2. 3 
Compound 3, obtained as a brownish white residue (16 mg), it has a molecular formula of 4 
C26H33N3O5 established by ESI-HRMS at m/z 468.2490 [M+H]
+ (calcd 468.2493), UV (MeOH) Ȝmax 5 
ORJİ 221 (5.41), 257 (4.84) nm. The MS/MS (Fig. 10S and Fig. 6B) showed three main fragments 6 
at m/z 337.1535, 279.1696 and 190.0858 for N-acetyl-phenylalanyl-phenylalanine [C20H21O3N2], 7 
phenylalanyl-leucine [C15H23O3N2], N-acetyl-L-phenylalanine [C11H12O2N íOH], respectively. The 8 
fragment for N-acetyl-L-phenylalanine was also observed in compound 2. The 1H-NMR spectrum 9 
(DMSO-d6, 400 MHz) (Table 2, Supporting Information Fig. 11S) was very similar to compound 2 10 
particularly in the aromatic region. However, additional proton signals were observed at the 11 
DOLSKDWLFUHJLRQDWįH 4.11 (m), 1.37 (m, 2H), 1.27 (m, 1H), 0.78 (d, 5.9, 3H) and 0.68 (d, 5.8, 3H).  12 
The 13C-NMR spectrum (DMSO-d6, 100 MHz) (Table 2, Supporting Information Fig. 12S) showed 13 
26 carbon signals instead of 20 when compared to compound 2 including six quaternary carbons, 14 
WHQDURPDWLFPHWKLQHVWKUHHPHWK\OHQHVWKUHHPHWK\OXQLWVDQGIRXUPHWKLQHVZLWKWKUHHĮ-CHNHs 15 
and one aliphatic methine. The TOCSY spectrum (Supporting Information Fig. 13S) indicated the 16 
presence of three amino acids, that included leucine and two units of phenylalanine.  The occurrence 17 
of leucine was established through the correlation of the NH* JURXSZLWKĮ-CHNH-2* (4.11), 18 
CH2-3
* (1.37) and the two methyl doublets Me-5* įH 0.68) and Me-6* įH 0.78). The connectivity 19 
of the three amino acid units were confirmed from the HMBC spectrum (Fig. 14S and Fig. 6B). As 20 
in compound 2, N-acetyl-phenylalanine was linked to a phenylalanine moiety by a similar pattern of 21 
cross SHDNV/HXFLQHZDVOLQNHGWRSKHQ\ODODQLQHWKURXJKFRUUHODWLRQVRIĮ-CHNH-2* DWįH 4.11 22 
with C-1''' RISKHQ\ODODQLQHDFDUER[\ODPLGHVLJQDODWįC 174.8 (C-1*) and a methylene carbon at 23 
 12 
40.6 (C-3*). The leucine moiety was further confirmed with correlations of CH2-3
* įH 1.37) with 1 
C-įC 50.6) and the two methyl doublets Me-įC 23.6) and Me-įC 21.6) which in return 2 
correlated with C-3*, C-įC 24.4). The configuration of the phenylalanine and leucine were 3 
DVVLJQHGWKURXJKD0DUIH\¶VUHDJHQWH[Seriment (Supporting Information Fig. 15S). Marfey 4 
derivatives of the hydrolysed products of compound 3 afforded C15H22N5O7 at m/z 384.1548 5 
[M+H]+ eluting at 13.80 min which paralleled to that of standard L-leucine at 13.82 min while the 6 
standard D-leucine had a retention time of 15.24 min. For phenylalanine, a similar result was 7 
obtained as in compound 2. Compound 3 (Fig. 4) was elucidated as N-acetyl-L-phenylalanyl-L-8 
phenylalanyl-L-leucine and isolated for the first time from the endophytic fungus Curvularia sp. 9 
Compound 3  was first described as a product of D-chymotrypsin-catalysed syntheses of peptides 10 
using various N-acylated amino acid or peptide esters as donors with amino acid derivatives or their 11 
peptide derivatives as acceptors [43].  12 
In this study, we were able to demonstrate a metabolomic-guided isolation protocol. The protocol 13 
afforded a logical systematic prediction of the biologically active target compounds. A combination 14 
of metabolomic- and a bioassay-guided protocol can efficiently predict the novelty of putative 15 
biologically active metabolites during the first stage of fractionation. This solves the problem on 16 
making false hypothesis on the dependence of bioactivity on the yield of respective metabolites in 17 
an active fraction or extract. The low yield of a very potent metabolite is challenging in determining 18 
the bioactive compound at the initial stage of the isolation work. In this study, a metabolomic-19 
guided protocol provided focus on the potency of the metabolite(s) present in a complex extract or 20 
fraction at micro- or nano-gram levels. 21 
 22 
Materials and Methods 23 
 13 
Fungal Material  1 
The endophytic fungus was isolated from fresh leaves of Terminalia laxiflora (Combretaceae) that 2 
were collected on the 15th of October 2010 from Al-Zohriya Gardens (30°02'45.0"N 31°13'32.5"E), 3 
Al-Zamalek in Giza, Egypt. Dr Therese L. Yousef from Orman Garden taxonomically identified the 4 
plant and a voucher specimen (No. 822) was deposited in her office in Orman Garden.  5 
The collected plant material was cut into small pieces, washed with sterilized demineralized water, 6 
then thoroughly surface sterilized with 70% isopropanol for 1-2 seconds and ultimately air dried for 7 
5 min under a laminar flow hood. With a sterile scalpel, outer tissues were removed from the plant 8 
samples and the inner tissues were carefully dissected under sterile conditions and laid over malt 9 
agar (MA) plates containing chloramphenicol. After four weeks of incubation at 30°C, hyphal tips 10 
of the fungi were removed and transferred to plates with fresh MA medium. Plates were prepared in 11 
duplicates to eliminate the possibility of contamination. Pure strains were isolated by repeated 12 
inoculation. The purified fungus was later transferred to rice media for scaling up. 13 
Small-scale extraction for screening, metabolomics profiling and dereplication.  14 
A plate of each fungal species was transferred into 250 ml flask and macerated overnight with ethyl 15 
acetate (EtOAc). The mycelia with the agar media was then homogenized with an ultra-turrax (IKA) 16 
and vacuum filtered. The filtered mycelia was again macerated sequentially 3× with 200 mL EtOAc 17 
and filtered. The pooled filtrate was then dried under vacuo, re-suspended in 200 mL H2O and 18 
partitioned 3× with 200 mL EtOAc in a separating funnel. (N.B. Re-suspension of the dried crude 19 
extract in H2O provided better separation of the aqueous and organic phase as well as a more 20 
efficient extraction of non- and semi-polar metabolites from the aqueous phase.) The ethyl acetate 21 
soluble portions were concentrated and dried under vacuo. The water-soluble portion was also 22 
 14 
concentrated and then passed over DiAION HP-20 (Supelco) column (100 x 600 mm) using 1 
methanol as an eluant. The methanol eluate was concentrated and dried under vacuo. 1 mg of each 2 
of the dried extract was subjected to HRMS analysis for metabolomics profiling and dereplication 3 
studies. LC-MS spectra were processed using Thermo Xcalibur 2.1 (Thermo Scientific). The 4 
program msconvert from ProteoWizard [44] was used to convert the raw data into separate positive 5 
and negative ionisation mzXML files. The files were then imported to the data mining software 6 
MZmine 2.10 (modified version as described by MacIntyre et al, 2014 [24]) for peak picking, 7 
deconvolution, deisotoping, alignment and formula prediction [24,25]. An in-house macro file with 8 
built in databases written in Excel was employed for further clean-up of background peaks from the 9 
media components and to dereplicate positive and negative ion peaks [24]. The Dictionary of 10 
Natural Products (DNP) 2015 database was used for the dereplication study. MestReNova (MNova) 11 
2.10 by Mestrelab Research S.L, was utilised to process all NMR data. SIMCA 14 analysis 12 
(Umetrics AB) was applied for multivariate data assessment. 13 
Samples at concentrations of 8-10 mg in 600 PL DMSO-d6 were sent to NMR analysis to monitor 14 
presence of lipids and steroids poorly detected by MS.  Sample in duplicates of 1 mg/mL 15 
concentration of each fungal extract from the malt agar plate (MA), 15-days liquid broth culture 16 
(LC), 7-days rice culture (RC.7DAY ),  and 30-days rice culture (RC.30DAY) were prepared and 17 
sent to Strathclyde Institute for Drug Research SIDR for bioassay against NF-kappaB and chronic 18 
myelogenous leukaemia (K562) cancer cell line.   19 
Fermentation, Extraction, and Isolation 20 
The fermentation was carried out in two Erlenmeyer flasks (1L each) on rice medium, which was 21 
prepared with 100 g of basmati rice and approximately 100 mL of demineralized water just enough 22 
to cover the rice layer. The rice media was autoclaved prior to inoculation. A 15-days fungal 23 
 15 
inoculum grown on petri dish was inoculated on the sterile rice medium and was allowed to grow at 1 
room temperature under static condition for 30 days. The fermentation was stopped by adding 500 2 
mL of EtOAc to each flask. Culture media were then cut into pieces to allow complete maceration 3 
and left for three days. Then filtration was done followed by repeated extraction with EtOAc until 4 
exhaustion. The combined EtOAc extracts were evaporated under vacuum, suspended in 200 mL 5 
H2O and partitioned by adding EtOAc (3x200 mL) in a separating funnel. The pooled EtOAc 6 
extracts were then concentrated under reduced pressure. The EtOAc extract was evaporated, 7 
dissolved in 10% aqueous MeOH and defatted by partitioning with n-hexane in a separating funnel. 8 
The MeOH soluble portion (2 g) was then dried and reconstituted with 30 mL of EtOAc to be 9 
loaded onto a 37 mm Biotage SNAP Ultra C18 Samplet 3 g frit and dried overnight under a fume 10 
hood. The dried loaded frit was placed over a Biotage C18 SNAP 60g silica gel cartridge (85 mm  x 11 
37 mm). Fractionation of the fungal extract was done using the Biotage IsoleraTM Spektra One 12 
Flash Purification System ISO-1SV. The flash system was equipped with photodiode array (PDA) 13 
detector with a wavelength range of 200 to 400 nm. The chromatographic run was accomplished 14 
using 0.1 % formic acid in water and 0.1 % formic acid in acetonitrile as solvents. A step-wise 15 
gradient elution was employed by commencing with 100 % water reaching to 50 % acetonitrile in 16 
70 minutes followed by another 20 minutes to 100 % acetonitrile with flow rate 12 mL/min. The 17 
fractions were concentrated, pooled according to their PDA chromatogram peaks and their purity on 18 
the TLC; which yielded 8 mg of 1 eluting at 30% acetonitrile, 15 mg of 2 and 16 mg of 3 that eluted 19 
at 45% and 50% acetonitrile, respectively. The pooled fractions were also further monitored for 20 
their purity by HPLC-HRMS. The generated HPLC-HRMS data was also use for metabolomics 21 
profiling of the fractions. 22 
 23 
 16 
Supporting information 1 
1D and 2D NMR, MS spectra of compounds 1, 2, and 3 as well as part of the experimental methods  2 
that includes the taxonomical identification of the fungi by molecular biological methods, Marfey 3 
derivatisation and bioscreening of the isolated compounds are available as Supporting Information. 4 
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Legends for Figures 
Fig. 1 - Heat map analysis of the mass spectral data of rice culture (RC) extracts at 7, 15, and 30 
days in comparison with the 15-days liquid broth culture extract and 30-days malt-agar (MA) 
culture extract. Legend: RC.7DAY = 7-days rice culture; RC.15DAY = 15-days rice culture; 





Fig. 2 - Scatter plot of the mass spectral data between (A) 15- and 7-days, (B) 15- and 30-days, 




Fig. 3 - (A) PCA score plot of the fractions where the blue dots are the inactive fractions and the 
red dots are the active fractions and (B) loading plot of the mass spectral data of crude extracts 
obtained from the rice and liquid culture of Curvularia along with the leaf extracts of its host 




Fig. 4 - Isolated compounds N-acetylphenylalanine (1), N-acetylphenylalanyl-L-phenylalanine 




Fig. 5 - (A) OPLS-DA score and (B) S-loading plots of the mass spectral data of active versus 
inactive fractions on NF-kappaB in K562 obtained from the 30-day rice culture of the endophytic 
fungus Curvularia. Shown data are the molecular weights. R2 = 1, Q2 = 1. (C) Relative 




Fig. 6 - HMBC correlations and MS/MS fragments of compounds 2 (A) and 3 (B). Red arrows 
(Ɣ) represent N-acetylphenylalanine moiety, blue arrows (Ɣ) for L-phenylalanine, and green (Ɣ) 




Table 1: Dereplication of the mass spectral data for the major total ion chromatogram peaks for the 30-days rice 
culture extract in comparison with the 15-days liquid broth culture extracts of Curvularia along with the butanol 
(BuOH) and ethyl acetate (EtOAc) leaf extracts of the host plant Terminalia laxiflora. The highlighted rows represent 
the isolated fungal metabolites with identical molecular formula as predicted by MZmine 2.10 (modified version). RT 
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afalanine, INN (1) 
C11H13NO3 


















Cladosporium herbarum [F] 







Roccella fuciformis [L] 











Aspergillus strain  
MFA 212 KACC [F] 







Aspergillus caespitosus [F] 











Cyathula capitata [P] 

















1 2 3 
įC (m) įH (m, J in Hz) įC (m) įH (m, J in 
Hz) 
įC (m) įH (m, J in Hz) 
1 173.9 (C)  168.9 (C)  168.7 (C)  
2 54.4 (CH) 4.37 (m) 50.5 (CH) 5.18 (m, 1H) 50.5 (CH) 5.19 (m) 
3A 37.5 (CH2)  3.04 (dd, 3.9, 13.6) 43.0 (CH2) 2.43-2.70 (m ) 43.0 (CH2) 2.40-2.61 (m) 
3B  2.82 (dd, 9.5, 13.6)  2.43-2.70 (m )  2.40-2.61 (m) 
1' 138.6 (C)  143.3 (C)  143.4  (C)  
2'/6' 128.7 (CH) 7.24 (m) 127.2 (CH) 7.05-7.27 (m) 127.1 (CH) 7.05-7.25 (m) 
3'/5' 129.7 (CH) 7.24 (m) 128.6 (CH) 7.05-7.27 (m) 128.6 (CH) 7.05-7.25 (m) 
4' 126.9 (CH) 7.24 (m) 127.3 (CH) 7.05-7.27 (m) 127.2 (CH) 7.05-7.25 (m) 
1'' 23.0 (CH3) 1.77 (s) 23.3 (CH3) 1.80 (s) 23.3 (CH3) 1.80 (s) 
2'' 169.6  (C)  168.8 (C)  168.8 (C)  
1'''   172.3 (C)  169.7 (C)  
2'''   49.8 (CH) 5.12 (m) 50.5 (CH) 5.09 (m) 
3'''   41.3 (CH2) 2.43-2.70 (m) 42.6 (CH2) 2.40-2.61 (m) 
1''''   142.8  (C)  142.8 (C)  
2''''/6''''   126.8 (CH) 7.05-7.27 (m) 126.9 (CH) 7.05-7.25 (m) 
3''''/5''''   128.7 (CH) 7.05-7.27 (m) 128.4 (CH) 7.05-7.25 (m) 
4''''   127.3 (CH) 7.05-7.27 (m) 127.2 (CH) 7.05-7.25 (m) 
1*     174.8 (C)  
2*     50.6 (CH) 4.11 (m) 
3*     40.6 (CH2) 1.37 (m) 
4*     24.4 (CH) 1.27 (m) 
5*     23.6 (CH3) 0.68 (d, 5.8) 
6*     21.6 (CH3) 0.78 (d, 5.9) 
NH  8.15 (d, 7.8)  8.35 (d, 8.1)  8.38 (d, 8.5) 
NH'''    8.39 (d, 8.5)  8.29 (d, 7.9) 
NH*      8.08 (d, 8.2) 
